| 标题 |
Interim Safety Results in Two Phase 1/2 Open-label, Dose-escalation Clinical Trials of Subretinal Gene Therapy with AGTC-401 (rAAV2tYF-PR1.7-hCNGB3) and AGTC-402 (rAAV2tYF-PR1.7-hCNGA3) in Subjects with Achromatopsia (ACHM) AGTC-401(rAAV 2 tYF-PR 1.7-hCNGB 3)和AGTC-402(rAAV 2 tYF-PR 1. 7-hCNGA 3)在色盲(ACHM)受试者中进行的两项1/2期开放标签、剂量升级临床试验的中期安全性结果
|
| 网址 | |
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)